RAFLF.US Raffles Medical Group Ltd
- Market cap
- USD 1.17B
- P/E
- 21.3x
- P/B
- 1.46x
- ROE
- 5.6%
- Dividend yield
- 3.66%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is RAFLF.US undervalued?
Graham numberRAFLF.US trades 17.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Raffles Medical Group Ltd fundamental analysis
No fundamental analysis for Raffles Medical Group Ltd yet.
Raffles Medical Group Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Raffles Medical Group Ltd
Raffles Medical Group Ltd provides private healthcare services in Singapore, Greater China, Vietnam, Cambodia, and Japan. It operates through four segments: Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services. The company operates Raffles Hospital that offers 24-hour acute and critical care; ambulance services and mobile medical calls to home, hotels, worksites, and onboard ships; and triage, emergency consultation, and inpatient ward admissio…
Full company profileRaffles Medical Group Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Raffles Medical Group Ltd annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 474M | 478M | 489M | 522M | 568M | 724M | 823M | 708M | 752M | 765M | 706M |
| Gross Profit | 382M | 384M | 390M | 411M | 432M | 581M | 640M | 316M | 486M | 137M | 310M |
| Operating Income | 81.9M | 80.1M | 84.2M | 76.2M | 88.4M | 121M | 196M | 116M | 82.5M | 89.2M | 76.3M |
| EBITDA | 97.7M | 96.0M | 104M | 107M | 125M | 161M | 237M | 146M | 136M | 142M | 120M |
| Net Income | 70.2M | 70.8M | 71.1M | 60.3M | 65.9M | 84.2M | 143M | 90.2M | 62.2M | 70.5M | 58.0M |
| EPS | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.08 | 0.05 | 0.03 | 0.04 | 0.03 |
| Balance Sheet | |||||||||||
| Total Assets | 901M | 1.01B | 1.12B | 1.28B | 1.40B | 1.55B | 1.50B | 1.53B | 1.53B | 1.43B | 1.38B |
| Total Liabilities | 219M | 254M | 300M | 428M | 490M | 569M | 467M | 484M | 466M | 374M | 342M |
| Shareholders' Equity | 666M | 734M | 800M | 841M | 899M | 961M | 1.02B | 1.03B | 1.05B | 1.06B | 1.04B |
| Cash & Short-term Investments | 112M | 98.3M | 106M | 152M | 203M | 265M | 253M | 344M | 344M | 311M | 262M |
| Total Debt | 30.4M | 79.2M | 116M | 203M | 230M | 198M | 96.1M | 125M | 88.2M | 87.4M | 34.2M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 78.9M | 82.7M | 91.5M | 111M | 133M | 160M | 196M | 189M | 86.3M | 106M | 129M |
| Capital Expenditure | 14.5M | 15.9M | 31.4M | 98.4M | 63.5M | 52.9M | 25.3M | 20.5M | 20.9M | 7.86M | 6.07M |
| Free Cash Flow | 64.4M | 66.8M | 60.1M | 12.8M | 69.7M | 107M | 171M | 169M | 65.3M | 98.0M | 123M |
| Ratios | |||||||||||
| ROE | 10.5% | 9.6% | 8.9% | 7.2% | 7.3% | 8.8% | 14.1% | 8.8% | 5.9% | 6.7% | 5.6% |
| ROA | 7.8% | 7.0% | 6.4% | 4.7% | 4.7% | 5.4% | 9.6% | 5.9% | 4.1% | 4.9% | 4.2% |
| Net Profit Margin | 14.8% | 14.8% | 14.5% | 11.5% | 11.6% | 11.6% | 17.4% | 12.7% | 8.3% | 9.2% | 8.2% |
| Debt to Equity | 0.05x | 0.11x | 0.15x | 0.24x | 0.26x | 0.21x | 0.09x | 0.12x | 0.08x | 0.08x | 0.03x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Raffles Medical Group Ltd dividends
- Dividend yield
- 3.66%
- Forward dividend
- 0.02 USD
- Payout ratio
- 65.6%
- Ex-dividend date
- May 12, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | SGD 46.2M | 0.02 | 65.6% |
| 2024 | SGD 44.6M | 0.02 | 71.6% |
| 2023 | SGD 70.7M | 0.04 | 78.4% |
| 2022 | USD 52.0M | 0.03 | 36.3% |
| 2021 | USD 37.3M | 0.02 | 44.4% |
| 2020 | USD 19.2M | 0.01 | 29.1% |
| 2019 | USD 18.0M | 0.01 | 29.8% |
| 2018 | USD 15.6M | 0.01 | 22.0% |
| 2017 | SGD 14.4M | 0.01 | 20.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 3:1 on May 9, 2016.
Who owns Raffles Medical Group Ltd
- Insiders 57.48%
- Institutions 9.73%
- Public & others 32.80%
- Shares outstanding 1.84B
- Free float 766M
Raffles Medical Group Ltd company profile
- Company name
- Raffles Medical Group Ltd
- Ticker
- RAFLF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 2,900
- Fiscal year end
- December
- Address
- 585 North Bridge Road, Singapore, Singapore, 188770
- Phone
- 65 6311 1111
- Website
- rafflesmedicalgroup.com
About Raffles Medical Group Ltd
Raffles Medical Group Ltd provides private healthcare services in Singapore, Greater China, Vietnam, Cambodia, and Japan. It operates through four segments: Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services. The company operates Raffles Hospital that offers 24-hour acute and critical care; ambulance services and mobile medical calls to home, hotels, worksites, and onboard ships; and triage, emergency consultation, and inpatient ward admission services. Its hospital also provides various services, including covid 19 test, health screening, executive medical centre, statutory health check, dental, and chinese medicine; and specialist centers for cancer, children, counselling, diabetes and endocrine, dialysis, eye, fertility, heart, internal medicine, neuroscience, nuclear medicine, orthopaedic, pain management, rehabilitation, skin and aesthetics, surgery, urology, and woman, as well as ear, nose, and throat. In addition, the company offers health screening and clinical trial services; Raffles health eStore; and healthcare insurance to corporates and individuals. Further, it is involved in trading of pharmaceutical and nutraceutical products, and diagnostic equipment; operations of medical clinics and other general medical services; provision of management, consultancy, and third-party administration services; medical laboratory and imaging centre business; and investment property activities. The company was founded in 1976 and is based in Singapore.
Raffles Medical Group Ltd management
10- Dr. Choon Yong LooExecutive Chairman & CEO · born 1949
- Dr. Qinghui LuCo-MD of Singapore Healthcare Div., Executive Medical Director & Executive Non Independent Director · born 1982
- Ms. Yeng Yeng WooChief Financial Officer
- Mr. Terence FooChief Technology Officer
- Ms. Joanna LeeSenior Manager of Communications
- Ms. Tanie EioChief Human Resources Officer
- Dr. Kenneth WuCo-MD of Singapore Healthcare Division
- Ms. Kimmy GohGroup Financial Controller
- Ms. Sien Ting WongJoint Company Secretary
- Ms. Chew Fern YapJoint Company Secretary